Search

Searching with a thematic focus on HIV and AIDS, ARVs, HIV and AIDS treatment and care

Showing 151-160 of 162 results

Pages

• Document

  Handbook on access to HIV/AIDS-related to treatment: a collection of information, tools and other resources for NGOs, CBOs and PLWHA groups

  International HIV/AIDS Alliance, 2002

  This handbook, aims to provide practical, experience based advice and examples for people and organisation working to improve access to HIV/AIDS treatment.The book explores care and treatment, providing an introduction to links between treatment and prevention and barriers to access to treatment.
• Document

  The FTAA, access to HIV/AIDS treatment, and human rights

  Human Rights Watch, 2002

  This briefing paper begins by giving an outline of the WTO’s Trade Related Aspects of Intellectual Property Agreement (TRIPS) and of the Doha declaration by WTO members, which states that countries can bypass patents in medical emergencies.The paper argues that countries in the Free Trade Area of the Americas (FTAA) should resist pressure from the Office of the United States Trade Representativ
• Document

  Introducing ARVs in resource-poor settings: expected and unexpected challenges and consequences

  Partners in Health, 2002

  In most industrialized countries, AIDS mortality has plunged sharply with the advent of antiretroviral therapy.
• Document

  Prevention of mother-to-child transmission of HIV in Asia: practical guidance for programs

  US Agency for International Development, 2002

  In most countries in Asia, pediatric incidences of HIV/AIDS are increasing.
• Document

  Expanding antiretroviral treatment in developing countries creates critical new challenges

  Center for Strategic and International Studies, Washington, 2002

  This paper examines the downstream implications of the new commitment to provide ART to people living with HIV/AIDS in developing countries.Specifically, the report asks, what new challenges are likely to emanate from expanded treatment programs that reach large numbers of HIV-infected persons?
• Document

  Scaling up anti-retroviral therapy in resource limited settings: treatment guidelines for a public health approach (2003 revision)

  World Health Organization WHO File, 2003

  This document from the World Health Organization (WHO) provides guidance on scaling up antiretroviral therapy (ART) in resource limited settings. It is intended primarily for use by Treatment Advisory Boards, national AIDS programme managers, and other senior level policymakers involved in the planning of national and international HIV care strategies in developing countries.
• Document

  Stigma, HIV/AIDS and prevention of mother-to-child transmission: a pilot study in Zambia, India, Ukraine and Burkina Faso

  Panos AIDS Programme, 2001

  Aims to assess and provide an initial analysis of the extent of perceived and enacted stigma, consider stigma in general and, more specifically, that surrounding mother-to-child transmission, and to explore what steps might be taken to alleviate it.Piolot research was conducted in India (South Asia), Ukraine (Eastern Europe), Burkina Faso (Francophone West Africa) and Zambia (Anglophone South
• Document

  Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries (4th Edition)

  Access to Essential Medicines Campaign, MSF, 2003

  The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear verified data. This information is intended for use by government and non-profit procurement agencies, as well as other bulk purchasers of ARVs, including health facilities and non governmental organizations (NGOs).
• Document

  Fighting AIDS together [children and AIDS]

  The Progress of Nations Report, UNICEF, 1999

  The world's children are benefiting from several decades of unprecedented health progress. Child-killing diseases are succumbing to vaccination campaigns and low-cost remedies, reducing death rates and improving the quality of young lives. But in about 30 developing countries, HIV/AIDS is threatening and even reversing these strides.
• Document

  Anti-Retroviral (ARV) Treatment in Developing Countries: Questions of Economics, Equity and Ethics [HIV/AIDS]

  AIDS Economics, World Bank, 1998

  Anti-retroviral (ARV) drugs have the potential to dramatically improve the health and extend the lives of some people with HIV/AIDS. Yet the high cost and demanding clinical requirements of these drugs put them out of reach of the vast majority of people with HIV.

Pages